These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38511603)

  • 1. Development and preclinical evaluation of equine-derived hyperimmune serum against SARS-CoV-2 infection in K-18 hACE2 transgenic (Tg) mice.
    Onen EA; Demirci EK
    Pol J Vet Sci; 2024 Mar; 27(1):61-74. PubMed ID: 38511603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RBD-VLP Vaccines Adjuvanted with Alum or SWE Protect K18-hACE2 Mice against SARS-CoV-2 VOC Challenge.
    Wong TY; Russ BP; Lee KS; Miller OA; Kang J; Cooper M; Winters MT; Rodriguez-Aponte SA; Dalvie NC; Johnston RS; Rader NA; Wong ZY; Cyphert HA; Martinez I; Shaligram U; Batwal S; Lothe R; Chandrasekaran R; Nagar G; Rajurkar M; Rao H; Bevere JR; Barbier M; Love JC; Damron FH
    mSphere; 2022 Aug; 7(4):e0024322. PubMed ID: 35968964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating Antibody Mediated Protection against Alpha, Beta, and Delta SARS-CoV-2 Variants of Concern in K18-hACE2 Transgenic Mice.
    Wong TY; Horspool AM; Russ BP; Ye C; Lee KS; Winters MT; Bevere JR; Miller OA; Rader NA; Cooper M; Kieffer T; Sourimant J; Greninger AL; Plemper RK; Denvir J; Cyphert HA; Barbier M; Torrelles JB; Martinez I; Martinez-Sobrido L; Damron FH
    J Virol; 2022 Mar; 96(6):e0218421. PubMed ID: 35080423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative pathology of the nasal epithelium in K18-hACE2 Tg mice, hACE2 Tg mice, and hamsters infected with SARS-CoV-2.
    Yu P; Deng W; Bao L; Qu Y; Xu Y; Zhao W; Han Y; Qin C
    Vet Pathol; 2022 Jul; 59(4):602-612. PubMed ID: 35094625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral and Anti-Inflammatory Therapeutic Effect of RAGE-Ig Protein against Multiple SARS-CoV-2 Variants of Concern Demonstrated in K18-hACE2 Mouse and Syrian Golden Hamster Models.
    Dhanushkodi NR; Prakash S; Quadiri A; Zayou L; Srivastava R; Shaik AM; Suzer B; Ibraim IC; Landucci G; Tifrea DF; Singer M; Jamal L; Edwards RA; Vahed H; Brown L; BenMohamed L
    J Immunol; 2024 Feb; 212(4):576-585. PubMed ID: 38180084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivated whole virion vaccine protects K18-hACE2 Tg mice against the Omicron SARS-CoV-2 variant via cross-reactive T cells and nonneutralizing antibody responses.
    Kruglov AA; Bondareva MA; Gogoleva VS; Semin IK; Astrakhantseva IV; Zvartsev R; Lunin AS; Apolokhov VD; Shustova EY; Volok VP; Ustyugov AA; Ishmukhametov AA; Nedospasov SA; Kozlovskaya LI; Drutskaya MS
    Eur J Immunol; 2024 Mar; 54(3):e2350664. PubMed ID: 38088236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mild and Severe SARS-CoV-2 Infection Induces Respiratory and Intestinal Microbiome Changes in the K18-hACE2 Transgenic Mouse Model.
    Seibert B; Cáceres CJ; Cardenas-Garcia S; Carnaccini S; Geiger G; Rajao DS; Ottesen E; Perez DR
    Microbiol Spectr; 2021 Sep; 9(1):e0053621. PubMed ID: 34378965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Delta SARS-CoV-2 Variant of Concern Induces Distinct Pathogenic Patterns of Respiratory Disease in K18-hACE2 Transgenic Mice Compared to the Ancestral Strain from Wuhan.
    Liu X; Mostafavi H; Ng WH; Freitas JR; King NJC; Zaid A; Taylor A; Mahalingam S
    mBio; 2022 Jun; 13(3):e0068322. PubMed ID: 35420469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Passive immunization with equine RBD-specific Fab protects K18-hACE2-mice against Alpha or Beta variants of SARS-CoV-2.
    Barbier M; Lee KS; Vikharankar MS; Rajpathak SN; Kadam N; Wong TY; Russ BP; Cyphert HA; Miller OA; Rader NA; Cooper M; Kang J; Sen-Kilic E; Wong ZY; Winters MT; Bevere JR; Martinez I; Devarumath R; Shaligram US; Damron FH
    Front Immunol; 2022; 13():948431. PubMed ID: 36091051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A longitudinal molecular and cellular lung atlas of lethal SARS-CoV-2 infection in K18-hACE2 transgenic mice.
    Choi S; Lee J; Kim S; Lee YW; Kim GC; Hong SM; An SH; Noh H; Kim KE; On D; Lee SG; Jang HJ; Kim SH; Kim J; Seo JS; Kim JJ; Park IH; Oh J; Kim DJ; Yoon JH; Seok SH; Lee YJ; Kim SY; Kim YB; Hwang JY; Lee HJ; Kim HB; Park JW; Yun JW; Shin JS; Seo JY; Nam KT; Choi KS; Kwon HK; Lee HY; Kim JK; Seong JK
    EBioMedicine; 2024 Jan; 99():104932. PubMed ID: 38118400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal Models of COVID-19: Transgenic Mouse Model.
    Park JG; Pino PA; Akhter A; Alvarez X; Torrelles JB; Martinez-Sobrido L
    Methods Mol Biol; 2022; 2452():259-289. PubMed ID: 35554912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective protection of ZF2001 against the SARS-CoV-2 Delta variant in lethal K18-hACE2 mice.
    Bian L; Bai Y; Gao F; Liu M; He Q; Wu X; Mao Q; Xu M; Liang Z
    Virol J; 2022 May; 19(1):86. PubMed ID: 35596222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human convalescent plasma protects K18-hACE2 mice against severe respiratory disease.
    Golden JW; Zeng X; Cline CR; Garrison AR; White LE; Fitzpatrick CJ; Kwilas SA; Bowling PA; Fiallos JO; Moore JL; Sifford WB; Ricks KM; Mucker EM; Smith JM; Hooper JW
    J Gen Virol; 2021 May; 102(5):. PubMed ID: 33961540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
    Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
    mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutting Edge: Characterization of Low Copy Number Human Angiotensin-Converting Enzyme 2-Transgenic Mice as an Improved Model of SARS-CoV-2 Infection.
    Bradshaw CM; Georgieva T; Tankersley TN; Taylor-Doyle T; Johnson L; Uhrlaub JL; Besselsen D; Nikolich JŽ
    J Immunol; 2024 Feb; 212(4):523-528. PubMed ID: 38197714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.
    Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J
    J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research.
    Dedoni S; Avdoshina V; Camoglio C; Siddi C; Fratta W; Scherma M; Fadda P
    Molecules; 2022 Jun; 27(13):. PubMed ID: 35807384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice.
    Winkler ES; Chen RE; Alam F; Yildiz S; Case JB; Uccellini MB; Holtzman MJ; Garcia-Sastre A; Schotsaert M; Diamond MS
    J Virol; 2022 Jan; 96(1):e0151121. PubMed ID: 34668780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.
    Kim SH; Kim J; Jang JY; Noh H; Park J; Jeong H; Jeon D; Uhm C; Oh H; Cho K; Jeon Y; On D; Yoon S; Lim SY; Kim SP; Lee YW; Jang HJ; Park IH; Oh J; Seo JS; Kim JJ; Seok SH; Lee YJ; Hong SM; An SH; Kim SY; Kim YB; Hwang JY; Lee HJ; Kim HB; Choi KS; Park JW; Seo JY; Yun JW; Shin JS; Lee HY; Kim K; Lee D; Lee H; Nam KT; Seong JK
    Front Immunol; 2022; 13():1055811. PubMed ID: 36457995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix Metalloproteinases Expression Is Associated with SARS-CoV-2-Induced Lung Pathology and Extracellular-Matrix Remodeling in K18-hACE2 Mice.
    Gutman H; Aftalion M; Melamed S; Politi B; Nevo R; Havusha-Laufer S; Achdout H; Gur D; Israely T; Dachir S; Mamroud E; Sagi I; Vagima Y
    Viruses; 2022 Jul; 14(8):. PubMed ID: 35893698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.